Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 8/20 | 0.67 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.67 |
| ▸ | CYP1A2 | P05177 | 5/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.61 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.61 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.61 |
| ▸ | CA1 | P00915 | 2/20 | 0.61 |
| ▸ | CA2 | P00918 | 2/20 | 0.61 |
| ▸ | CA7 | P43166 | 1/20 | 0.61 |
| ▸ | CA9 | Q16790 | 1/20 | 0.61 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.58 |
| ▸ | CASP1 | P29466 | 1/20 | 0.58 |
| ▸ | CASP7 | P55210 | 1/20 | 0.58 |
| ▸ | HBB | P68871 | 1/20 | 0.58 |
| ▸ | CES2 | O00748 | 1/20 | 0.52 |
| ▸ | CES1 | P23141 | 1/20 | 0.52 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Anthracene SCHEMBL3187575 | 0.96 | CYP2A6 (0.73) | CYP2A6ALOX12CYP1A2ALDH1A1HSD17B10 | |
| Anthracene SCHEMBL5713428 | 0.96 | CYP2A6 (0.73) | CYP2A6ALOX12CYP1A2ALDH1A1HSD17B10 | |
| Naphthalene SCHEMBL29173720 | 0.92 | CYP2A6 (0.67) | CYP2A6ALOX12CYP1A2ALDH1A1HSD17B10 | |
| Anthracene SCHEMBL17912426 | 0.92 | CYP2A6 (0.67) | CYP2A6ALOX12CYP1A2ALDH1A1HSD17B10 | |
| Anthracene SCHEMBL2833889 | 0.91 | CYP2A6 (0.64) | CYP2A6ALOX12CYP1A2ALDH1A1HSD17B10 | |
| Anthracene SCHEMBL5713429 | 0.91 | CYP2A6 (0.64) | CYP2A6ALOX12CYP1A2ALDH1A1HSD17B10 | |
| Anthracene SCHEMBL29352043 | 0.91 | CYP2A6 (0.64) | CYP2A6ALOX12CYP1A2ALDH1A1HSD17B10 | |
| Anthracene SCHEMBL7703 | 0.91 | CYP2A6 (0.64) | CYP2A6ALOX12CYP1A2ALDH1A1HSD17B10 | |
| Benz(B)Anthracene SCHEMBL4591619 | 0.88 | CYP2A6 (0.61) | CYP2A6ALOX12CYP1A2ALDH1A1HSD17B10 | |
| Anthracene SCHEMBL23302274 | 0.87 | CYP2A6 (0.58) | CYP2A6ALOX12CYP1A2ALDH1A1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8071769-B2 | Aromatic monomer- and conjugated polymer-metal complexes | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-12-06 | — | — | US | disclosed |
| US-20110172426-A1 | AROMATIC MONOMER- AND CONJUGATED POLYMER-METAL COMPLEXES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-07-14 | — | — | US | disclosed |
| US-20100160631-A1 | AROMATIC MONOMER- AND CONJUGATED POLYMER-METAL COMPLEXES | SUMITOMO CHEMICHAL COMPANY, LIMITED (JP) | 2010-06-24 | — | — | US | disclosed |
| US-7705528-B2 | Aromatic monomer-and conjugated polymer-metal complexes | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-04-27 | — | — | US | disclosed |
| US-7651746-B2 | Halogenated bisdiarylaminopolycyclic aromatic compounds and polymers thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2010-01-26 | — | — | US | disclosed |
| US-7432303-B2 | Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states | Bowen, J. Phillip (US) | 2008-10-07 | — | — | US | disclosed |
| US-7399504-B2 | Method of preparing an insoluble polymer film on a substrate from a soluble polymer containing labile solubilizing groups | DOW GLOBAL TECHNOLOGIES INC. (US) | 2008-07-15 | — | — | US | disclosed |
| US-20070126345-A1 | Halogenated bisdiarylaminopolycylic aromatic compounds and polymers thereof | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2007-06-07 | — | — | US | disclosed |
| US-20050148599-A1 | Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states | UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. | 2005-07-07 | — | — | US | disclosed |
| WO-2005049546-A1 | HALOGENATED BISDIARYLAMINOPOLYCYLIC AROMATIC COMPOUNDS AND POLYMERS THEREOF | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2005-06-02 | — | — | WO | disclosed |
| US-20050106324-A1 | Method of preparing an insoluble polymer film on a substrate from a soluble polymer containing labile solubilizing groups | DOW GLOBAL TECHNOLOGIES LLC | 2005-05-19 | — | — | US | disclosed |
| WO-2005036666-A2 | METHOD OF PREPARING AN INSOLUBLE POLYMER FILM ON A SUBSTRATE FROM A SOLUBLE POLYMER CONTAINING LABILE SOLUBILIZING GROUPS | DOW GLOBAL TECHNOLOGIES INC. (US) | 2005-04-21 | — | — | WO | disclosed |
| WO-2005016945-A1 | AROMATIC MONOMER-AND CONJUGATED POLYMER-METAL COMPLEXES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2005-02-24 | — | — | WO | disclosed |
| US-20050031900-A1 | Aromatic monomer-and conjugated polymer-metal complexes | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2005-02-10 | — | — | US | disclosed |
| WO-2005010081-A1 | AROMATIC MONOMER-AND CONJUGATED POLYMER-METAL COMPLEXES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2005-02-03 | — | — | WO | disclosed |
| US-20050014023-A1 | Aromatic monomer- and conjugated polymer-metal complexes | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2005-01-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100160631-A1 | AROMATIC MONOMER- AND CONJUGATED POLYMER-METAL COMPLEXES | DDT, TYR, DDC | CYP2A6 4047/4885ALOX12 3061/4885CYP1A2 3684/4885 |
| US-20050148599-A1 | Chalcone and its analogs as agents for the inhibition of angiogenesis and related disease states | FLT1, VEGFA, FLT4 | CYP2A6 1341/4885ALOX12 1581/4885CYP1A2 655/4885 |
| US-20110172426-A1 | AROMATIC MONOMER- AND CONJUGATED POLYMER-METAL COMPLEXES | DDT, TYR, DDC | CYP2A6 4047/4885ALOX12 3061/4885CYP1A2 3684/4885 |
| US-20070126345-A1 | Halogenated bisdiarylaminopolycylic aromatic compounds and polymers thereof | AHR, AADAC, ARNT | CYP2A6 168/4885ALOX12 313/4885CYP1A2 133/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.